Opinion · 31 Jan 2025
Review articlePublished 30 Sep 2023
Mucosal Autoimmune Disorders: Deciphering the Code
Department of Microbiology and Immunology Center, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Mucosal autoimmune disorders represent a complex and enigmatic group of diseases that afflict various mucosal surfaces within the human body, including the gastrointestinal tract, oral cavity, and respiratory system. These conditions, such as Crohn’s disease, ulcerative colitis, celiac disease, and oral lichen planus, share a common feature the immune system’s misguided attack on its own tissues, leading to chronic inflammation and tissue damage. This abstract provides an overview of the current state of knowledge regarding mucosal autoimmune disorders, with a focus on recent advancements in understanding their etiology, pathogenesis, and potential therapeutic strategies. Deciphering the code of mucosal autoimmune disorders involves unraveling the intricate interplay of genetic susceptibility, environmental triggers, and dysregulated immune responses. Genetic studies have identified numerous susceptibility loci associated with these conditions, shedding light on the genetic underpinnings of mucosal autoimmunity. Environmental factors, including diet, microbiota composition, and exposure to pathogens, have also been implicated in disease initiation and progression. The immune system’s role in mucosal autoimmunity is multifaceted, with both innate and adaptive immunity playing pivotal roles. Dysregulation of immune checkpoints, cytokine signaling pathways, and the gut-associated lymphoid tissue contributes to the perpetuation of chronic inflammation and tissue damage. Understanding these immune mechanisms is crucial for the development of targeted therapies. Recent advancements in the field of mucosal autoimmune disorders have brought forth promising therapeutic avenues. Biologic agents targeting specific immune pathways, such as anti-TNF-alpha and anti-IL-23 agents, have shown efficacy in managing diseases like Crohn’s disease and ulcerative colitis. Additionally, personalized medicine approaches, guided by genetic and immunological profiling, hold potential for tailoring treatments to individual patients.
Keywords
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 31 Jan 2025
The Interplay Between Mucosal Immunity and Gut Microbiota: Implications for Inflammatory Diseases and Autoimmune Disorders
Opinion · 31 Jan 2025
Immunopathology of Mucosal Tissues: Understanding Inflammatory Mechanisms and Their Impact on Autoimmune Diseases
Short communication · 27 Apr 2023
Mucosal Immunity and Autoimmune Diseases: Breaking the Tolerance Barrier
Article · 5 Mar 2026
Understanding Autoimmune Disorders: Immune Dysregulation, Clinical Patterns, and Management Approaches
More from this journal
The newest in Journal of Mucosal Immunology Research.
Perspective · 29 May 2025
Gut T-cell Regulation: IBD Therapies
Perspective · 29 May 2025
Gut Microbiota: Diet, Inflammation, and Homeostasis
Perspective · 29 May 2025
Airway Mucosa: Inflammation, Microbiome, and Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Mucosal Immunology Research
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Nick J”
